Rimonabant for neurocognition in schizophrenia: A 16-week double blind randomized placebo controlled trial
Titel:
Rimonabant for neurocognition in schizophrenia: A 16-week double blind randomized placebo controlled trial
Auteur:
Boggs, Douglas L. Kelly, Deanna L. McMahon, Robert P. Gold, James M. Gorelick, David A. Linthicum, Jared Conley, Robert R. Liu, Fang Waltz, James Huestis, Marilyn A. Buchanan, Robert W.